Small-Cap
FDA Approves YARTEMLEA as First-Ever Treatment for TA-TMA
Omeros secures landmark approval for a life-saving therapy in adults and children following stem cell transplant The U.S. Food and...
Highway Holdings Moves to Expand Automotive Capabilities With German Acquisition
Proposed majority stake in Regent-Feinbau aims to strengthen OEM exposure and unlock growth in China and Europe Highway Holdings Limited...
A Breakthrough in Knee Osteoarthritis: Enlivex Reports Promising Six-Month Results for Allocetra
Sustained pain reduction, improved mobility, and strong safety profile position Allocetra™ as a potential game-changer for aging patients Enlivex Therapeutics...
KULR Technology Posts Record Q3 Revenue as It Expands Deep Into Frontier Tech and Bitcoin Infrastructure
Despite widening losses, the company accelerates investments in aerospace batteries, AI robotics, and Bitcoin mining partnerships KULR Technology Group (KULR),...
Intensity Therapeutics Publishes Promising Phase 1/2 Results for Novel Cancer Drug INT230-6
Study in eBioMedicine shows strong disease control and survival benefits across multiple tumor types with minimal toxicity Intensity Therapeutics (INTS),...
Scienture Launches Commercial Sales of Arbli™, the First FDA-Approved Ready-to-Use Losartan Suspension
$256 million U.S. market opportunity drives expansion as company kicks off multi-channel promotional campaign Scienture Holdings (SCNX) announced the official...
Replimune Reports Promising New Data for Acral Melanoma Treatment at ESMO 2025
RP1 combined with nivolumab shows meaningful tumor response in rare and aggressive skin cancer Replimune Group (REPL), a clinical-stage biotechnology...
Praxis Announces Breakthrough Phase 3 Results for Ulixacaltamide in Essential Tremor Treatment
Positive data from Essential3 program marks major step toward first targeted therapy for millions living with essential tremor Praxis Precision...
Genprex Shares Gain as Positive Preclinical Lung Cancer Data to Be Presented at Global Oncology Conference
REQORSA® gene therapy shows promise against hard-to-treat ALK-positive non-small cell lung cancer Clinical-stage gene therapy developer Genprex (GNPX) announced that...
Dragonfly Energy Secures Nevada Tech Hub Funding to Strengthen Lithium Battery Innovation
$300,000 award to support modernization, workforce training, and growth in Nevada’s clean energy economy Dragonfly Energy Holdings (DFLI), the Reno-based...
